ArticleRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2022

Pre-treatment immune status predicts disease control in NSCLCs treated with chemoradiation and durvalumab.

Maria Thor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.